| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/23/2003 | WO2002032927A3 Haplotypes of the scya20 gene |
| 01/23/2003 | WO2002029413A3 An assay for rhabdovirus inhibitors |
| 01/23/2003 | WO2002029059A3 Nogo receptor homologs |
| 01/23/2003 | WO2002026986A3 Identification and cloning of a full-length human cink-related gene, mist (mast cell immunoreceptor signal transducer) |
| 01/23/2003 | WO2002026775A3 Compositions and methods for regulating apoptosis |
| 01/23/2003 | WO2002026254A3 Non-replicative particulate vaccine delivery system and methods of making and using same |
| 01/23/2003 | WO2002024739A3 Spas-1 cancer antigen |
| 01/23/2003 | WO2002024732A3 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) |
| 01/23/2003 | WO2002022659A3 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II |
| 01/23/2003 | WO2002020569A3 Mammalian genes; related reagents and methods |
| 01/23/2003 | WO2002018585A3 Packaging of positive-strand rna virus replicon particles |
| 01/23/2003 | WO2002016598A3 Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers |
| 01/23/2003 | WO2002016553A3 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 01/23/2003 | WO2002015661A3 Inhibitors of hiv replication and method of treatment of hiv infections |
| 01/23/2003 | WO2002014364A3 Rattlesnake venom gland proteins |
| 01/23/2003 | WO2002012272A3 Therapeutic anti-melanoma compounds |
| 01/23/2003 | WO2002011761A3 Vaccine against rsv |
| 01/23/2003 | WO2002010412A3 Novel regulatory genes involved in condensed tannin synthesis in plants |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2002010204A3 G protein-coupled receptors |
| 01/23/2003 | WO2002008262A3 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/23/2003 | WO2002002771A3 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
| 01/23/2003 | WO2002002607A3 Acid-modified arabinogalactan protein composition |
| 01/23/2003 | WO2002000720A3 Novel human gaba receptors and polynucleotides encoding the same |
| 01/23/2003 | WO2001097856A3 An orphan nuclear receptor |
| 01/23/2003 | WO2001096584A3 Materials and methods for the control of nematodes |
| 01/23/2003 | WO2001093851A3 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 01/23/2003 | WO2001090358A3 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | WO2001089548A3 Pharmaceutical use of fibulin-1 |
| 01/23/2003 | WO2001089364A3 Hcv variants |
| 01/23/2003 | WO2001077334A9 Lactococcus lactis genome, polypeptides and uses |
| 01/23/2003 | WO2001077311A3 Transcription factor stress-related proteins and methods of use in plants |
| 01/23/2003 | WO2001073031A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/23/2003 | WO2001072768A3 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 01/23/2003 | WO2001066568A3 Use of recombinant antigens to determine the immune status of an animal |
| 01/23/2003 | WO2001063279A3 Method of identifying toxic agents using differential gene expression |
| 01/23/2003 | US20030018995 Plants with a modified flower and seed development |
| 01/23/2003 | US20030018990 Cabbage proteinase inhibitor gene confers resistance against plant pests |
| 01/23/2003 | US20030018988 Animal model for use in the diagnosis and treatment of epileptic and nervous system disorders |
| 01/23/2003 | US20030018987 Animal model for use in the diagnosis and treatment of eating, apoptosis and infectious disorders |
| 01/23/2003 | US20030018984 IGF-I expression system and methods of use |
| 01/23/2003 | US20030018438 Binding compounds and methods for identifying binding compounds |
| 01/23/2003 | US20030018349 Nucleic acid molecules specific for bacterial antigens and uses thereof |
| 01/23/2003 | US20030018184 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 01/23/2003 | US20030018182 A cDNA encoding a non-endogenous, constitutively activated version of a human G protein-coupled receptor |
| 01/23/2003 | US20030018181 Antiinflammatory agents; culturing; isolation of fusion protein |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018178 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030018169 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018167 Genetic engineering |
| 01/23/2003 | US20030018165 Uses of suppressive macrophage activation factors |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030018006 Gene expression; plasmids; cancer therapy |
| 01/23/2003 | US20030018004 Vector |
| 01/23/2003 | US20030018003 Rhob as a suppressor of cancer cell growth and cell transformation |
| 01/23/2003 | US20030018001 Antitumor agents; anticarcinogenic agents |
| 01/23/2003 | US20030017992 Crystalline forms |
| 01/23/2003 | US20030017991 Substrates and assays for beta-secretase activity |
| 01/23/2003 | US20030017990 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 01/23/2003 | US20030017988 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 01/23/2003 | US20030017987 Using histones |
| 01/23/2003 | US20030017986 Topical administering bactericide and permeable adjustment protein |
| 01/23/2003 | US20030017983 Controlling apoptosis; antiinflammatory agents |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017980 Detecting breast cancer |
| 01/23/2003 | US20030017979 Antibody and chemokine constructs and their use in the treatment of infections and immunological diseases |
| 01/23/2003 | US20030017978 Transgenic plant |
| 01/23/2003 | US20030017977 Methods of treating inflammatory skin diseases |
| 01/23/2003 | US20030017973 Fraction extracted from archaebacteria for cosmetic purposes |
| 01/23/2003 | US20030017967 Insecticides; microbiocides; for plants, seeds |
| 01/23/2003 | US20030017966 MC4-R as target for the identification of compounds used to treat drug addiction |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017586 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
| 01/23/2003 | US20030017585 Polypeptide for use in the treatment of cancer, nervous system and autoimmune disorders |
| 01/23/2003 | US20030017584 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 01/23/2003 | US20030017571 Polynucleotide compositions encoding broad spectrum delta-endotoxins |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017562 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 01/23/2003 | US20030017555 Nucleotide sequences coding polypeptide for use in the generation of amino acids for use in animal nutrients and human medicines |
| 01/23/2003 | US20030017553 Nucleotide sequences for transcriptional regulation in corynebacterium glutamicum |
| 01/23/2003 | US20030017550 Nucleotide sequences coding polypeptide for use in the treatment of viral, neoplastic, multiple sclerosis and immunological disorders |
| 01/23/2003 | US20030017548 Proteins for use in treatment of gastrointestinal disorders |
| 01/23/2003 | US20030017547 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017546 Analogues of Kunitz protease inhibitor domain of amyloid precursor protein bind to and inhibit activity of serine proteases including kallikrein, plasmin, and coagulation factors VIIa, IXa, Xa, XIa, and XIIa; for treating blood loss |
| 01/23/2003 | US20030017545 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders |
| 01/23/2003 | US20030017544 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders |
| 01/23/2003 | US20030017543 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017542 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017540 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017539 Novel nucleic acid sequences encoding G-protein coupled receptors |
| 01/23/2003 | US20030017538 Genetically engineered protein for use as diagnostic tool in gentic analysis |
| 01/23/2003 | US20030017537 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 01/23/2003 | US20030017536 Novel polypeptide |
| 01/23/2003 | US20030017535 Nucleotide sequences coding polypeptide for use in the prevention and treatment of atherosclerosis, cardiovascular and cancerous disorders |
| 01/23/2003 | US20030017533 Slo2 and Slo4, novel potassium channel proteins from human brain |
| 01/23/2003 | US20030017530 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017529 Peptide for use in human therapeutics and diagnostics |
| 01/23/2003 | US20030017528 Human orphan G protein-coupled receptors |